Taware, R. and Taunk, K. and Kumar, T.V.S. and Pereira, J.A.M. and Câmara, J.S. and Nagarajaram, H.A. and Kundu, G.C. and Rapole, S. (2020) Extracellular volatilomic alterations induced by hypoxia in breast cancer cells. Metabolomics, 16 (2).

Mahalunkar, S. and Yadav, A.S. and Gorain, M. and Pawar, V. and Braathen, R. and Weiss, S. and Bogen, B. and Gosavi, S.W. and Kundu, G.C. (2019) Functional design of pH-responsive folate-targeted polymer-coated gold nanoparticles for drug delivery and in vivo therapy in breast cancer. International Journal of Nanomedicine., 14. pp. 8285-8302.

Tomar, D. and Yadav, A.S. and Kumar, D. and Bhadauriya, G. and Kundu, G.C. (2019) Non-coding RNAs as potential therapeutic targets in breast cancer. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms.

Butti, R. and Gunasekaran, V.P. and Kumar, T.V.S. and Banerjee, P. and Kundu, G.C. (2018) Breast cancer stemcells: Biology and therapeutic implications. International Journal Of Biochemistry & Cell Biology, 107. pp. 38-52. ISSN 2018 Dec5;107:38-52.

Prasad, R. and Chauhan, D.S. and Yadav, A.S. and Devrukhkar, J. and Singh, B. and Gorain, M. and Temgire, M. and Bellare, J. and Kundu, G.C. and Srivastava, R.A. (2018) biodegradable fluorescent nanohybrid for photo-driven tumor diagnosis and tumor growth inhibition. Nanoscale, 10 (40). pp. 19082-19091. ISSN 10(40):19082-19091

Butti, R. and Kumar, T.V. and Nimma, R. and Kundu, G.C. (2018) Impact of semaphorin expression on prognostic characteristics in breast cancer. Current Topics in Medicinal Chemistry, 10. pp. 79-88.

Yadav , A.S. and Pandey, P.R. and Butti , B. and Radharani , NNV. and Roy, R. and Bhalara, S.R. and Gorain , M. and Kundu , G.C. and Kumar , D. (2018) The biology and therapeutic implications of tumor dormancy and reactivation. Front Oncol. , 8. p. 72.

Kumar, D. and Haldar, S. and Gorain , M. and Kumar , S. and Mulani, F.A. and Yadav, A.S. and Miele, L. and Thulasiram, H.V. and Kundu , G.C. (2018) Epoxyazadiradione suppresses breast tumor growth through mitochondrial depolarization and caspase-dependent apoptosis by targeting PI3K/Akt pathway. BMC Cancer. 2018 Jan 8;18(1):52, 18 (1). p. 52.

Butti , R and Das, S and Gunasekaran , V.P. and Yadav, A.S. and Kumar, D. and Kundu , G.C. (2018) Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges. Molecular Cancer, 17 (34).

Wadhwani, S.A. and Gorain , M. and Banerjee , P. and Shedbalkar, U.U. and Singh, R and Kundu , G.C. and Chopade, B.A. (2017) Green synthesis of selenium nanoparticles using Acinetobacter sp. SW30: optimization, characterization and its anticancer activity in breast cancer cells. International Journal of Nanomedicine , 12 (12). 6841-6855 .

Ghosh , A. and Dasgupta , D. and Ghosh , A. and Roychoudhury , S. and Kumar , D. and Gorain , M. and Butti , R. and Datta , S. and Agarwal , S. and Gupta , S. and Krishna Dhali , G. and Chowdhury , A. and Schmittgen , T.D. and Kundu , G.C. and Banerjee , S. (2017) MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2. Cell Death Dis. 2017 Mar; 8(3): e2706., 8 (3). e2706..

Kumar , D. and Pandey , P.R. and Kundu , G.C. (2017) Notch1-MAPK signaling axis is essential in CD133+ melanoma initiating cells. Journal of Cell Signaling, 2 (4). p. 4.

Kumar , D. and Gorain , M. and Goutam, K and Kundu , G.C. (2017) Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma. Molecular Cancer , 16 (1). ISSN Mol Cancer 16 (1), 7. 2017 Jan 30.

Kumar, D. and Kumar, S. and Gorain, M. and Tomar, D. and Patil , H.S. and Radharani, N.N. and Kumar, T.V. and Patil, T.V. and Thulasiram, H.V. and Kundu , G.C. (2016) Signaling Axis Regulates CD133(+) Cancer Stem Cell-Mediated Melanoma Growth and Angiogenesis. J. Invest Dermatol., 136 (12). pp. 2462-2474. ISSN 2016 Dec;136(12):2462-2474

Mukherjee, S. and Manna, A. and Bhattacharjee , P. and Mazumdar , M. and Saha , S. and Chakraborty, S. and Guha, D. and Adhikary, A. and Jana, D. and Gorain, M. and Mukherjee, S.A. and Kundu, G.C. and Sarkar, D.K. and Das, T. (2016) Non-migratory tumorigenic intrinsic cancer stem cells ensure breast cancer metastasis by generation of CXCR4+ migrating cancer stem cells. Oncogene , 35. pp. 4937-4948.

Ghosh , S. and More , P. and Derle , A. and Kitture , R. and Kale , T. and Gorain, M. and Avasthi , A. and Markad, P. and Kundu , G.C. and Kale , S. and Dhavale , D.D. and Bellare , J. and Chopade, B.A. (2015) Diosgenin functionalized iron oxide nanoparticles as novel nanomaterial. J Nanosci Nanotechnol. 2015 Dec;15(12):9464-72., 15 (12). pp. 9464-9472.

Rustagi , Y. and Jaiswal , H.K. and Rawal , K. and Kundu , G.C. and Rani , V. (2015) Comparative characterization of cardiac development specific microRNAs: Fetal regulators for future,. PLoS One. 2015 Oct 14;10(10):e0139359. doi: 10.1371/journal.pone.0139359. eCollection 2015., 10 (10). e0139359.-e0139359.. ISSN PLoS One. 2015 Oct 14;10(10):e0139359. doi: 10.1371/journal.pone.0139359. eCollection 2015.

Nanjappa , V. and Renuse, S. and Sathe, G.J. and Raja, R. and Syed, N. and Radhakrishnan , A. and Subbannayya, T. and Patil , A. and Marimuthu, A. and Sahasrabuddhe, N.A. and Guerrero-Preston , R. and Somani, B.L. and Nair, B. and Kundu , G.C. and Prasad , T.K. and Califano , J.A and Gowda, H. and Sidransky , D. and Pandey , A. and Chatterjee, A. (2015) Chronic exposure to chewing tobacco selects for overexpression of stearoyl-CoA desaturase in normal oral keratinocytes. Cancer Biol Ther. , 16 (11). 1593 -1603. .

Ghosh , S and Adhikary , A. and Chakraborty , S. and Bhattacharjee , P. and Mazumder, M. and Putatunda , S. and Gorain, M. and Chakraborty , A and Kundu, G.C. and Das , T. and Sen , P.C. (2015) Cross-talk between endoplasmic reticulum (ER) stress and the MEK/ERK pathway potentiates apoptosis in human triple negative breast carcinoma cells: role of a dihydropyrimidone, nifetepimine. The Journal of Biological Chemistry (JBC), 290 (7). pp. 3936-3949. ISSN 2015 Feb 13;290(7):3936-49.

Butti, R. and Ghosh, P. and Kumar , V.S. and Totakura, K.V.S. and Radharani , N. and Venkata, N. and Nimma, R. and Kundu , G.C. (2015) Role of Osteopontin in Tumor Microenvironment: A New Paradigm in Cancer Therapy. In: Multi-Targeted Approach to Treatment of Cancer,. Springer International Publishing Switzerland, pp. 113-125. ISBN 978-3-319-12252-6

Byagari , K. and Shanavas , A. and Rengan , A.K. and Kundu , G.C. and Srivastava , R. (2014) Biocompatible amphiphilic pentablock copolymeric nanoparticles for anti-cancer drug delivery. J Biomed Nanotechnol. , 10 (1). pp. 109-119.

Taware, R. and Abnave , P. and Patil , D.K. and Rajamohananan, P.R. and Raja , R. and Soundararajan , G. and Kundu , G.C. and Ahmad , A. (2014) Isolation, purification and characterization of Trichothecinol-A produced by endophytic fungus Trichothecium sp. and its antifungal, anticancer and antimetastatic activities. Sustainable Chemical Processes 2014, 2:8, 2 (8). pp. 1-9.

Ray, G. and Shetti, D. and Yadav , A. and Kundu , G.C. (2014) Nanomedicine: Therapeutic Applications and Limitations. In: Handbook of Research on Diverse Applications of Nanotechnology in Biomedicine, Chemistry, and Engineering. IGI Global.

Bandopadhyay , M. and Kundu , G.C. and , . (2014) Osteopontin as a therapeutic target for cancer. Expert Opinion on Therapeutic Targets , 18 (8).

Kumar , S. and Sharma , P. and Kumar , D. and Chakraborty , G. and Gorain, M. and Kundu , G.C. (2013) Functional Characterization of Stromal Osteopontin in Melanoma Progression and Metastasis. PLoS One, 8 (7). e69116- e69116. ISSN July 2013 | Volume 8 | Issue 7 | e69116

Syed , A. and Saraswati , S. and Kundu , G.C. and Ahmad , A. (2013) Biological synthesis of silver nanoparticles using the fungus Humicola sp. and evaluation of their cytoxicity using normal and cancer cell lines. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 114. pp. 144-147.

Raja, R. and Kale , S. and Thorat , D. and Soundararajan , G. and Lohite , K. and Mane , A. and Karnik , S. and Kundu, G.C. (2013) Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1a-mediated VEGF-dependent angiogenesis. Oncogene. pp. 1-12.

Panda , J.J. and Kaul , A. and Kumar , S. and Alam , S. and Mishra , A.K. and Kundu , G.C. and Chauhan , V.S. (2013) Modified dipeptide-based nanoparticles: vehicles for targeted tumor drug delivery. Nanomedicine , 8 (12). pp. 1927-1942.

Haldar , S. and Kumar , S. and Kolet , S.P. and Patil , H.S. and Kumar , D. and Kundu , G.C. and Thulasiram , H.V. (2013) One-Pot Fluorescent Labeling Protocol for Complex Hydroxylated Bioactive Natural Products. Journal of Organic Chemistry, 78. pp. 10192-10202.

Kale , S. and Raja1 , R. and Thorat , D. and Soundararajan, G. and Patil , T.V. and Kundu , G.C. (2013) Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via a9b1 integrin S Kale1,. Oncogene. pp. 1-12.